144 related articles for article (PubMed ID: 30916604)
1. Role of
Wahid B
J Interferon Cytokine Res; 2020 Sep; 40(9):454-459. PubMed ID: 30916604
[TBL] [Abstract][Full Text] [Related]
2. An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load.
Wahid B; Rafique S; Saleem K; Ali A; Idrees M
J Interferon Cytokine Res; 2018 Mar; 38(3):122-128. PubMed ID: 29565742
[TBL] [Abstract][Full Text] [Related]
3. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
4. Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients.
Lee CM; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH; Yen YH
J Formos Med Assoc; 2016 Jun; 115(6):440-4. PubMed ID: 26786212
[TBL] [Abstract][Full Text] [Related]
5. Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients.
Naz Z; Wahid B; Usman S; Saleem K; Rafique S; Ali A; Idrees M
J Interferon Cytokine Res; 2018 Jun; 38(6):255-260. PubMed ID: 29920131
[TBL] [Abstract][Full Text] [Related]
6. Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs.
Naveed M; Ali A; Sheikh N; Rafique S; Idrees M
APMIS; 2020 Apr; 128(4):326-334. PubMed ID: 31863490
[TBL] [Abstract][Full Text] [Related]
7. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
Shin EC; Han JW; Kang W; Kato T; Kim SJ; Zhong J; Kim S; Park SH; Sung PS; Watashi K; Park JY; Windisch MP; Oh JW; Wakita T; Han KH; Jang SK
Viruses; 2020 Mar; 12(3):. PubMed ID: 32168867
[No Abstract] [Full Text] [Related]
8. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte Landscape after Chronic
Ghosh A; Romani S; Kottilil S; Poonia B
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050486
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
Wong MT; Chen SS
Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
[TBL] [Abstract][Full Text] [Related]
11. The Coronavirus Transmissible Gastroenteritis Virus Evades the Type I Interferon Response through IRE1α-Mediated Manipulation of the MicroRNA miR-30a-5p/SOCS1/3 Axis.
Ma Y; Wang C; Xue M; Fu F; Zhang X; Li L; Yin L; Xu W; Feng L; Liu P
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185587
[TBL] [Abstract][Full Text] [Related]
12. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
[TBL] [Abstract][Full Text] [Related]
13. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy.
Amaddeo G; Nguyen CT; Maillé P; Mulé S; Luciani A; Machou C; Rodrigues A; Regnault H; Mallat A; Laurent A; Lafdil F; Hézode C; Pawlotsky JM; Calderaro J
Liver Int; 2020 Jan; 40(1):74-82. PubMed ID: 31444947
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule inhibitors of ubiquitin-specific protease 7 enhance type-I interferon antiviral efficacy by destabilizing SOCS1.
Yuan Y; Miao Y; Zeng C; Liu J; Chen X; Qian L; Wang X; Qian F; Yu Z; Wang J; Qian G; Fu Q; Lv H; Zheng H
Immunology; 2020 Mar; 159(3):309-321. PubMed ID: 31691271
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes.
Burchill MA; Salomon MP; Golden-Mason L; Wieland A; Maretti-Mira AC; Gale M; Rosen HR
PLoS Pathog; 2021 Aug; 17(8):e1009799. PubMed ID: 34370798
[TBL] [Abstract][Full Text] [Related]
17. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
18. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlation of liver function tests with suppression of cytokine signaling (SOCS1) gene expression in HCV infected patients: A real-world clinical experience.
Bin Wahid S; Ain QU; Quraishi A; Wahid B
J Med Virol; 2020 Feb; 92(2):257-259. PubMed ID: 31535716
[TBL] [Abstract][Full Text] [Related]
20. Innate Immunity in Hepatitis C Virus Infection.
Schwerk J; Negash A; Savan R; Gale M
Cold Spring Harb Perspect Med; 2021 Feb; 11(2):. PubMed ID: 32341066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]